David Michael Johnson - 05 Jan 2023 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder
Issuer symbol
AURA
Transactions as of
05 Jan 2023
Net transactions value
+$20,811
Form type
4
Filing time
09 Jan 2023, 16:55:37 UTC
Previous filing
30 Dec 2022
Next filing
09 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Purchase $3,000 +300 +1.8% $10.00 17,300 05 Jan 2023 By NEJ09 IRREVOCABLE TRUST F1
transaction AURA Common Stock Purchase $960 +96 +0.56% $10.00 17,096 05 Jan 2023 By NEJ12 IRREVOCABLE TRUST F2
transaction AURA Common Stock Purchase $7,350 +700 +4% $10.50 18,000 06 Jan 2023 By NEJ09 IRREVOCABLE TRUST F1
transaction AURA Common Stock Purchase $9,501 +904 +5.3% $10.51 18,000 06 Jan 2023 By NEJ12 IRREVOCABLE TRUST F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F2 The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.